The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad

Background : Diabetic retinopathy (DR) is a serious complication of longstanding type 2 diabetes mellitus (T2DM), which is the forerunner in causing blindness and visual disability in the world. The aim of this study was to investigate the relationship between the activity of tissue plasminogen acti...

Full description

Saved in:
Bibliographic Details
Main Author: Jasmiad, Nurbadriah
Format: Thesis
Language:English
Published: 2021
Subjects:
Online Access:https://ir.uitm.edu.my/id/eprint/93978/1/93978.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-uitm-ir.93978
record_format uketd_dc
spelling my-uitm-ir.939782024-08-22T03:43:41Z The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad 2021 Jasmiad, Nurbadriah Diabetes Mellitus Background : Diabetic retinopathy (DR) is a serious complication of longstanding type 2 diabetes mellitus (T2DM), which is the forerunner in causing blindness and visual disability in the world. The aim of this study was to investigate the relationship between the activity of tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) in tears and serum of patients with DR and those without DR. Method: T2DM patients with DR (n=26) were enrolled in this study and compared to those without DR (n= 29). Blood and tear samples were obtained from both groups. The level of PAI-1 and tPA were measured in both the serum and tears. Anthropometric measurements, HbA1c, renal and lipid profile were also obtained. Results: Patients with DR had significantly longer disease duration and higher systolic blood pressure compared to those without DR. Serum PAI-1 level was significantly higher in patients with DR compared to those without DR, 32.72 (IQR 32.52) vs 21.37 (IQR 14.93) ng/mL, respectively (p<0.05). However, tear PAI-1 were comparable in both groups. Serum and tear tPA levels in both groups were also comparable (p>0.05). Among patients with DR, there were no significant correlations between tear and serum of both biomarkers. Patients without DR showed a moderate positive correlation between serum and tear tPA levels with a coefficient of 0.363, albeit no statistical significance. Patients with DR demonstrated a significant positive correlation between levels of tears PAI-1 and BMI (r=0.555, p=0.026). In the group without DR, there was a statistically significant positive correlation between serum level of PAI-1 with urine albumin creatinine ratio (UACR) (r=0.501, p=0.013). Conclusion: This present study demonstrated significantly greater serum PAI-1 levels in patients with DR compared to those without DR. No significant correlations between tears and serum PAI-1 and tPA were observed. The tear PAI-1 levels positively correlated with BMI among patients with DR, whilst serum PAI-1 level positively correlated with UACR among patients without DR. Thus, the roles of tear biomarkers remain relevant for further investigations. Faculty of Medicine 2021 Thesis https://ir.uitm.edu.my/id/eprint/93978/ https://ir.uitm.edu.my/id/eprint/93978/1/93978.pdf text en public masters Universiti Teknologi MARA Faculty of Medicine
institution Universiti Teknologi MARA
collection UiTM Institutional Repository
language English
topic Diabetes Mellitus
spellingShingle Diabetes Mellitus
Jasmiad, Nurbadriah
The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
description Background : Diabetic retinopathy (DR) is a serious complication of longstanding type 2 diabetes mellitus (T2DM), which is the forerunner in causing blindness and visual disability in the world. The aim of this study was to investigate the relationship between the activity of tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) in tears and serum of patients with DR and those without DR. Method: T2DM patients with DR (n=26) were enrolled in this study and compared to those without DR (n= 29). Blood and tear samples were obtained from both groups. The level of PAI-1 and tPA were measured in both the serum and tears. Anthropometric measurements, HbA1c, renal and lipid profile were also obtained. Results: Patients with DR had significantly longer disease duration and higher systolic blood pressure compared to those without DR. Serum PAI-1 level was significantly higher in patients with DR compared to those without DR, 32.72 (IQR 32.52) vs 21.37 (IQR 14.93) ng/mL, respectively (p<0.05). However, tear PAI-1 were comparable in both groups. Serum and tear tPA levels in both groups were also comparable (p>0.05). Among patients with DR, there were no significant correlations between tear and serum of both biomarkers. Patients without DR showed a moderate positive correlation between serum and tear tPA levels with a coefficient of 0.363, albeit no statistical significance. Patients with DR demonstrated a significant positive correlation between levels of tears PAI-1 and BMI (r=0.555, p=0.026). In the group without DR, there was a statistically significant positive correlation between serum level of PAI-1 with urine albumin creatinine ratio (UACR) (r=0.501, p=0.013). Conclusion: This present study demonstrated significantly greater serum PAI-1 levels in patients with DR compared to those without DR. No significant correlations between tears and serum PAI-1 and tPA were observed. The tear PAI-1 levels positively correlated with BMI among patients with DR, whilst serum PAI-1 level positively correlated with UACR among patients without DR. Thus, the roles of tear biomarkers remain relevant for further investigations.
format Thesis
qualification_level Master's degree
author Jasmiad, Nurbadriah
author_facet Jasmiad, Nurbadriah
author_sort Jasmiad, Nurbadriah
title The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
title_short The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
title_full The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
title_fullStr The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
title_full_unstemmed The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
title_sort association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / nurbadriah jasmiad
granting_institution Universiti Teknologi MARA
granting_department Faculty of Medicine
publishDate 2021
url https://ir.uitm.edu.my/id/eprint/93978/1/93978.pdf
_version_ 1811768779409981440